Holen Sie sich die Stockscreener-App
126.96
0.41%
0.52
Handel nachbörslich:
126.96
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey
Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance
Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada
Repligen at William Blair Conference: Innovation Drives Growth - Investing.com
Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus
Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance
Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance
Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus
Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance
Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World
Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus
Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times
Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com
Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK
Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance
Repligen at RBC Capital Markets: Strategic Growth Insights - Investing.com Australia
Insider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN) - GuruFocus
Repligen Co. (NASDAQ:RGEN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Mercer Global Advisors Inc. ADV Sells 1,039 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World
Contrasting Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE) - Defense World
Pioneering innovation in bioprocessing: Repligen’s growing impact in the area and symbiotic relationship with WWETB - Business Post
Why Repligen Corp Stock Might Make Sense If Bought Today - Stocksregister
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance
Stifel Financial Corp Grows Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World
Things To Consider Before Buying Repligen Corp (NASDAQ: RGEN) - Stocksregister
Global Hollow Fiber Filtration Market Set to Witness - openPR.com
M&A activity dominates Q1, nearly 99% total med-tech deal value - BioWorld MedTech
Repligen (NASDAQ:RGEN) Upgraded to “Hold” at StockNews.com - Defense World
Investor’s Toolkit: Key Ratios for Assessing Repligen Corp (RGEN)’s Performance - DWinneX
Repligen Corporation to Present at Upcoming May Investor Conferences - Yahoo Finance
Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright - Defense World
Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RG - GuruFocus
Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RGEN Stock News - GuruFocus
Leerink Partnrs Has Pessimistic View of Repligen Q2 Earnings - Defense World
Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare - Insider Monkey
There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - Sete News
Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’ - Insider Monkey
Wolfe Research Upgrades Repligen (NASDAQ:RGEN) to “Outperform” - Defense World
BlackRock, Inc. Reduces Stake in Repligen Corp: An In-Depth Anal - GuruFocus
Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years - Insider Monkey
Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings) - Benzinga
Wolfe Research Upgrades Repligen Corp (RGEN) to an Outperform from a Peer perform - knoxdaily.com
RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty - Yahoo Finance
Repligen (RGEN) Price Target Adjusted by RBC Capital Amid Market Trends | RGEN Stock News - GuruFocus
Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com
Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript - Insider Monkey
Repligen: Q1 Earnings Snapshot - CT Insider
0.46%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):